KCNAB2 and non-small cell lung carcinoma: Moreover, KCNAB2 overexpression largely suppressed in vitro migration (Fig. 2E), invasion (Fig. 2F), and motility (Fig. 2G) of NSCLC cells, tested by “Transwell”, “Matrigel Transwell” and phagokinetic track motility assays, respectively.